Study Stopped
Lack of resourses and regulatory agency approval
Clinical Trial of a Rehabilitation Device Based on Electrostimulation for Obstructive Sleep Apnoea
1 other identifier
interventional
17
1 country
2
Brief Summary
The aim of this study is to evaluate in a clinical trial a rehabilitation device for patients with obstructive sleep apnoea (OSA) based on oropharyngeal electrical stimulation, which strengthens the dilating muscles of the upper airway, improves mechanical laryngopharyngeal sensitivity and improves OSA. Furthermore, to perform experimental electrotherapy, nasoendoscopy, polygraphy and polysomnography tests with the device in order to calculate thresholds of functional and sensory intensities on the dilating muscles of the upper airway in patients with OSA. These tests also include the detection of signals that measure breathing events during sleep in patients with OSA in order to use them in the control mechanisms of the electrostimulation device. Assess the effects and safety of the device in a group of five healthy volunteers for preliminary results. Finally, to evaluate in a small group of patients with OSA the device capacity to stimulate the upper-airway dilating muscles and to reduce the Apnea-Hypopnea Index (AHI) and oxygen desaturation indices when the electrostimulation device is used over a medium-term period (eight weeks) with morning and evening therapy sessions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2020
CompletedFirst Posted
Study publicly available on registry
October 29, 2020
CompletedStudy Start
First participant enrolled
July 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
Study Completion
Last participant's last visit for all outcomes
July 1, 2027
April 13, 2026
April 1, 2026
1 year
September 22, 2020
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement of the apnoea-hypopnea index (AHI) during sleep
A median reduction of 10 on the AHI is expected with the intervention.
2 months
Secondary Outcomes (8)
Desaturation index
2 months
sleep time spent under 90% oxygen saturation (T90)
2 months
oxygen saturation by pulse oximetry (SpO2) nadir
2 months
Mean SpO2
2 months
Number of patients who lower one or more categories in the severity of OSA
2 months
- +3 more secondary outcomes
Study Arms (1)
Assigned Interventions
EXPERIMENTALPatients will undergo a conventional flexible nasopharyngeal laryngoscopy in which the degree of obstruction and the laryngopharyngeal sensitivity during wakefulness will be determined. Electrostimulation will be applied at different submandibular points with increasing intensity until the contraction of the dilation muscles of the airway or until the patient cannot tolerate the electrostimulation. The presence of contraction of stimulated muscles will be determined by external and endoscopic inspection.
Interventions
Experimental tests with transcutaneous electrical stimulation at different intensities and at the points of the submandibular region previously explored will be conducted first of all on the five healthy volunteer subjects. During these tests, the neuromuscular thresholds of the upper airway, the most effective points of electrostimulation and the tolerance of intervention will be determined. The determination of the functional threshold will be made by clinical evaluation of the subject during stimulation.
Eligibility Criteria
You may qualify if:
- Patients over 18 years of age with confirmed OSA (four with mild OSA, four with moderate OSA and four with severe OSA) who sign their informed consent to participate in the study.
You may not qualify if:
- Pregnancy
- Basal polysomnography that does not meet validity criteria to be interpreted.
- Haemorrhagic diathesis (to avoid risk of severe epistaxis during nasal endoscopy).
- Glasgow scale less than 15 (to avoid confusion with sensory or motor laryngopharyngeal involvement due to neurological disease that compromises the state of consciousness).
- Basal oxygen saturation by awake pulse oximetry below 88%.
- Patients with more than 5% of the total apnoea events being of central origin. (to avoid including patients with central sleep apnoea in whom laryngopharyngeal electrostimulation would have no effect).
- Inflammatory or infectious lesions on the face or neck
- Skin hypersensitivity
- Anaesthetic areas, burns, bruises or recent wounds in the area of electrical stimulation
- Cardiac pacemakers or other telemetry-controlled devices,
- History of maxillofacial or pharyngeal surgery.
- Active cancer
- Tumours of the laryngopharyngeal tract.
- Significant mental and/or behavioural conditions or inability of the patient to cooperate during the examination/intervention.
- Epilepsy
- +10 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fundación Neumologica Colombianalead
- Universidad de la Sabanacollaborator
Study Sites (2)
Fundacion Neumologica Colombiana
Bogotá, Bogota D.C., 11111, Colombia
Universidad de La Sabana
Chía, Cundinamarca, Colombia
Related Publications (8)
Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med. 2005 Feb 1;142(3):187-97. doi: 10.7326/0003-4819-142-3-200502010-00010. No abstract available.
PMID: 15684207BACKGROUNDGallas S, Marie JP, Leroi AM, Verin E. Sensory transcutaneous electrical stimulation improves post-stroke dysphagic patients. Dysphagia. 2010 Dec;25(4):291-7. doi: 10.1007/s00455-009-9259-3. Epub 2009 Oct 24.
PMID: 19856025BACKGROUNDGillick BT, Zirpel L. Neuroplasticity: an appreciation from synapse to system. Arch Phys Med Rehabil. 2012 Oct;93(10):1846-55. doi: 10.1016/j.apmr.2012.04.026. Epub 2012 May 18.
PMID: 22613094BACKGROUNDGuilleminault C, Hill MW, Simmons FB, Dement WC. Obstructive sleep apnea: electromyographic and fiberoptic studies. Exp Neurol. 1978 Oct;62(1):48-67. doi: 10.1016/0014-4886(78)90040-7. No abstract available.
PMID: 729676BACKGROUNDHowlett OA, Lannin NA, Ada L, McKinstry C. Functional electrical stimulation improves activity after stroke: a systematic review with meta-analysis. Arch Phys Med Rehabil. 2015 May;96(5):934-43. doi: 10.1016/j.apmr.2015.01.013. Epub 2015 Jan 26.
PMID: 25634620BACKGROUNDKezirian EJ, Boudewyns A, Eisele DW, Schwartz AR, Smith PL, Van de Heyning PH, De Backer WA. Electrical stimulation of the hypoglossal nerve in the treatment of obstructive sleep apnea. Sleep Med Rev. 2010 Oct;14(5):299-305. doi: 10.1016/j.smrv.2009.10.009. Epub 2010 Jan 29.
PMID: 20116305BACKGROUNDSchulte W, Scholze H, Werries E. Specificity of a cysteine proteinase of Entamoeba histolytica towards the alpha 1-CB2 peptide of bovine collagen type I. Mol Biochem Parasitol. 1987 Aug;25(1):39-43. doi: 10.1016/0166-6851(87)90016-8.
PMID: 2890103BACKGROUNDPage SJ, Cunningham DA, Plow E, Blazak B. It takes two: noninvasive brain stimulation combined with neurorehabilitation. Arch Phys Med Rehabil. 2015 Apr;96(4 Suppl):S89-93. doi: 10.1016/j.apmr.2014.09.019.
PMID: 25813373BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Luis F Giraldo, MD, PhD
Fundación Neumológica Colombiana
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD. Pulmonary Medicine, Interventional Pulmonology
Study Record Dates
First Submitted
September 22, 2020
First Posted
October 29, 2020
Study Start (Estimated)
July 1, 2026
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
The patients clinical data will be entered into an anonymized database hosted on RedCap platform